Su J. Hong

Puch'on, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 148 publications

Prior Cancer and Survival in Patients With Esophageal Squamous Cell Carcinoma.

Prior Cancer and Survival in Patients With Esophageal Squamous Cell Carcinoma.

Journal: JAMA network open

Published: February 20, 2026

Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process.

Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process.

Journal: BMC infectious diseases

Published: January 18, 2026

Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial.

Tegoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial.

Journal: Helicobacter

Published: October 14, 2025

Artificial Intelligence-Driven Drafting of Chest X-Ray Reports: 2025 Position Statement From the Korean Society of Thoracic Radiology Based on an Expert Survey.

Artificial Intelligence-Driven Drafting of Chest X-Ray Reports: 2025 Position Statement From the Korean Society of Thoracic Radiology Based on an Expert Survey.

Journal: Korean journal of radiology

Published: April 19, 2025

Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study.

Comparative Efficacy of Potassium-Competitive Acid Blocker-Based Triple Therapy with Tegoprazan versus Vonoprazan for Helicobacter pylori Eradication: A Randomized, Double-Blind, Active-Controlled Pilot Study.

Journal: Gut and liver

Published: February 07, 2025

Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Therapy for First-Line Eradication of Helicobacter pylori: A Meta-Analysis of Randomized Controlled Trials.

Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Therapy for First-Line Eradication of Helicobacter pylori: A Meta-Analysis of Randomized Controlled Trials.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 02, 2025

Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment.

Korean Registry on the Current Management of Helicobacter pylori (K-Hp-Reg): Interim Analysis of Adherence to the Revised Evidence-Based Guidelines for First-Line Treatment.

Journal: Gut and liver

Published: October 21, 2024

Impact of Deep Learning-Based Image Conversion on Fully Automated Coronary Artery Calcium Scoring Using Thin-Slice, Sharp-Kernel, Non-Gated, Low-Dose Chest CT Scans: A Multi-Center Study.

Impact of Deep Learning-Based Image Conversion on Fully Automated Coronary Artery Calcium Scoring Using Thin-Slice, Sharp-Kernel, Non-Gated, Low-Dose Chest CT Scans: A Multi-Center Study.

Journal: Korean journal of radiology

Published: September 07, 2024

Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III Study.

Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III Study.

Journal: Gut and liver

Published: August 28, 2024

Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial.

Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial.

Journal: Neurogastroenterology and motility

Published: July 03, 2024

Efficacy and safety of rebamipide/nizatidine in patients with erosive gastritis: A randomized, multicenter, phase 4 study.

Efficacy and safety of rebamipide/nizatidine in patients with erosive gastritis: A randomized, multicenter, phase 4 study.

Journal: World journal of gastroenterology

Published: June 20, 2024

Association of peripheral leukocyte telomere length with patients with rheumatoid arthritis with a focus on interstitial lung disease.

Association of peripheral leukocyte telomere length with patients with rheumatoid arthritis with a focus on interstitial lung disease.

Journal: The Korean journal of internal medicine

Published: April 29, 2024

Showing 1-12 of 148

Last Updated: 09/26/2026